Calidi Biotherapeutics, Inc.

After a month and a half initial public offering drought, two biopharmaceutical companies – Neumora Therapeutics, Inc. and RayzeBio, Inc. – launched IPOs in the US and grossed $561m combined on 14

Mydecine, JHU Expand Pact Focused Initially On Smoking Cessation Mydecine Innovations Group Inc. and Johns Hopkins University said on 18 August that they will undertake a five-year collaboration t